Inhibition of class I HDACs imprints adipogenesis toward oxidative and brown-like phenotype

Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Apr;1865(4):158594. doi: 10.1016/j.bbalip.2019.158594. Epub 2020 Jan 2.

Abstract

Obesity is characterized by uncontrolled expansion of adipose tissue mass, resulting in adipocyte hypertrophy (increased adipocyte size) and hyperplasia (increased number of adipocytes). The number of adipose cells is directly related to adipocyte differentiation process from stromal vascular cells to mature adipocytes. It is known that epigenetic factors influence adipose differentiation program. However, how specific epigenome modifiers affect white adipocyte differentiation and metabolic phenotype is still matter of research. Here, we provide evidence that class I histone deacetylases (HDACs) are involved both in the differentiation of adipocytes and in determining the metabolic features of these cells. We demonstrate that inhibition of class I HDACs from the very first stage of differentiation amplifies the differentiation process and imprints cells toward a highly oxidative phenotype. These effects are related to the capacity of the inhibitor to modulate H3K27 acetylation on enhancer regions regulating Pparg and Ucp1 genes. These epigenomic modifications result in improved white adipocyte functionality and metabolism and induce browning. Collectively, our results show that modulation of class I HDAC activity regulates the metabolic phenotype of white adipocytes via epigenetic imprinting on a key histone mark.

Keywords: Adipose differentiation; Browning; Histone deacetylases; Oxidative metabolism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes, Brown / cytology
  • Adipocytes, Brown / drug effects*
  • Adipocytes, Brown / metabolism
  • Adipocytes, White / cytology
  • Adipocytes, White / drug effects
  • Adipocytes, White / metabolism
  • Adipogenesis / drug effects*
  • Animals
  • Cell Line
  • Epigenesis, Genetic / drug effects*
  • Histone Deacetylase Inhibitors / pharmacology*
  • Histone Deacetylases / genetics
  • Histone Deacetylases / metabolism*
  • Humans
  • Mice
  • Obesity / drug therapy
  • Obesity / genetics
  • Obesity / metabolism
  • Oxidative Stress / drug effects

Substances

  • Histone Deacetylase Inhibitors
  • Histone Deacetylases